Innovative medical solutions
for long-standing challenges

Our unique technology addresses the issues that arise from water-based delivery systems with a novel, proprietary, non-aqueous formulation. This innovative approach has been implemented in the Gvoke Pre-Filled Syringe and the Gvoke HypoPen, newly approved by the FDA.

Learn more about our Gvoke offerings

Solutions for many therapeutic areas

We're currently developing innovative, ready-to-use solutions for various therapeutic categories to remove many associated treatment burdens and ultimately improve patients' lives.

See how we can help

Progress for severe hypoglycemia and epilepsy are just the start

While clinical trials are currently underway to investigate how Xeris' formulation technology can be applied for hypoglycemia and epilepsy management, Xeris' novel formulation also has the potential for use in single-use auto-injectors, prefilled syringes, ready-to-use vials, and pumps.

Uncover what tomorrow brings

A different approach

At Xeris, we're always looking for ways to really impact patients' lives. That's why we offer a novel formulation technology to bring ready-to-use, liquid-stable injectables to patients whose lives are often burdened by the “time of use” preparation routine.

Explore what we have to offer
BACK
TO TOP